List of redirects

Jump to navigation Jump to search

Showing below up to 50 results in range #52,911 to #52,960.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. The Living Guidelines: Recommendations for Revascularization with PCI and CABG in Patients with Chronic Stable Angina View the Current CLASS IIa Guidelines → Chronic stable angina treatment
  2. The Living Guidelines: Recommendations for Revascularization with PCI and CABG in Patients with Chronic Stable Angina View the Current CLASS IIb Guidelines → Chronic stable angina treatment
  3. The Living Guidelines: Recommendations for Revascularization with PCI and CABG in Patients with Chronic Stable Angina View the Current CLASS I Guidelines → Chronic stable angina treatment
  4. The Living Guidelines: Recommendations for UA/NSTEMI in Drug and Substance Abusers View the Current CLASS III Guidelines → Unstable angina / non ST elevation myocardial infarction drug and substance abusers#ACC / AHA Guidelines (DO NOT EDIT)
  5. The Living Guidelines: Recommendations for UA/NSTEMI in Drug and Substance Abusers View the Current CLASS IIa Guidelines → Unstable angina / non ST elevation myocardial infarction drug and substance abusers#ACC / AHA Guidelines (DO NOT EDIT)
  6. The Living Guidelines: Recommendations for UA/NSTEMI in Drug and Substance Abusers View the Current CLASS IIb Guidelines → Unstable angina / non ST elevation myocardial infarction drug and substance abusers#ACC / AHA Guidelines (DO NOT EDIT)
  7. The Living Guidelines: Recommendations for UA/NSTEMI in Drug and Substance Abusers View the Current CLASS I Guidelines → Unstable angina / non ST elevation myocardial infarction drug and substance abusers#ACC / AHA Guidelines (DO NOT EDIT)
  8. The Living Guidelines: Recommendations for UA/NSTEMI in Prinzmetal’s Angina View the Current CLASS III Guidelines → Unstable angina / non ST elevation myocardial infarction prinzmetal's angina#ACC / AHA Guidelines (DO NOT EDIT)
  9. The Living Guidelines: Recommendations for UA/NSTEMI in Prinzmetal’s Angina View the Current CLASS IIb Guidelines → Unstable angina / non ST elevation myocardial infarction prinzmetal's angina#ACC / AHA Guidelines (DO NOT EDIT)
  10. The Living Guidelines: Recommendations for UA/NSTEMI in Prinzmetal’s Angina View the Current CLASS I Guidelines → Unstable angina / non ST elevation myocardial infarction prinzmetal's angina#ACC / AHA Guidelines (DO NOT EDIT)
  11. The Living Guidelines: Recommendations for UA/NSTEMI in patients with Cardiovascular Syndrome X View the Current CLASS III Guidelines → Unstable angina / non ST elevation myocardial infarction cardiovascular syndrome x#ACC / AHA Guidelines (DO NOT EDIT)
  12. The Living Guidelines: Recommendations for UA/NSTEMI in patients with Cardiovascular Syndrome X View the Current CLASS IIb Guidelines → Unstable angina / non ST elevation myocardial infarction cardiovascular syndrome x#ACC / AHA Guidelines (DO NOT EDIT)
  13. The Living Guidelines: Recommendations for UA/NSTEMI in patients with Cardiovascular Syndrome X View the Current CLASS I Guidelines → Unstable angina / non ST elevation myocardial infarction cardiovascular syndrome x#ACC / AHA Guidelines (DO NOT EDIT)
  14. The Living Guidelines: Recommendations for choosing diagnostic tests during follow up in patients with Chronic Stable Angina View the Current CLASS I Guidelines → Chronic stable angina patient follow-up
  15. The Living Guidelines: STEMI Anticoagulants as Ancillary Therapy View the Current CLASS I Guidelines → ST elevation myocardial infarction anticoagulant and antithrombotic therapy
  16. The Living Guidelines: STEMI Anticoagulants for STEMI patients who do not go reperfusion therapy View the Current CLASS III Guidelines → ST elevation myocardial infarction management of patients who were not reperfused
  17. The Living Guidelines: STEMI Anticoagulants for STEMI patients who do not go reperfusion therapy View the Current CLASS IIa Guidelines → ST elevation myocardial infarction management of patients who were not reperfused
  18. The Living Guidelines: STEMI Antiplatelet Agents / Anticoagulants Therapy: Aspirin View the Current CLASS IIa Guidelines → ST elevation myocardial infarction aspirin therapy
  19. The Living Guidelines: STEMI Antiplatelet Agents / Anticoagulants Therapy: Aspirin View the Current CLASS I Guidelines → ST elevation myocardial infarction aspirin therapy
  20. The Living Guidelines: STEMI Antiplatelet Agents / Anticoagulants Therapy: Clopidogrel View the Current CLASS IIa Guidelines → ST elevation myocardial infarction secondary prevention
  21. The Living Guidelines: STEMI Antiplatelet Agents / Anticoagulants Therapy: Clopidogrel View the Current CLASS I Guidelines → ST elevation myocardial infarction secondary prevention
  22. The Living Guidelines: STEMI Antiplatelet Agents / Anticoagulants Therapy: Warfarin View the Current CLASS I Guidelines → ST elevation myocardial infarction secondary prevention
  23. The Living Guidelines: STEMI Facilitated PCI View the Current CLASS III Guidelines → ST elevation myocardial infarction facilitated percutaneous coronary intervention
  24. The Living Guidelines: STEMI Facilitated PCI View the Current CLASS IIb Guidelines → ST elevation myocardial infarction facilitated percutaneous coronary intervention
  25. The Living Guidelines: STEMI Immediate (or Emergency) Invasive Strategy and Rescue PCI View the Current CLASS III Guidelines → ST elevation myocardial infarction percutaneous coronary intervention following fibrinolytic administration
  26. The Living Guidelines: STEMI Immediate (or Emergency) Invasive Strategy and Rescue PCI View the Current CLASS IIa Guidelines → ST elevation myocardial infarction percutaneous coronary intervention following fibrinolytic administration
  27. The Living Guidelines: STEMI Immediate (or Emergency) Invasive Strategy and Rescue PCI View the Current CLASS IIb Guidelines → ST elevation myocardial infarction percutaneous coronary intervention following fibrinolytic administration
  28. The Living Guidelines: STEMI Immediate (or Emergency) Invasive Strategy and Rescue PCI View the Current CLASS I Guidelines → ST elevation myocardial infarction percutaneous coronary intervention following fibrinolytic administration
  29. The Living Guidelines: STEMI Influenza Vaccination View the Current CLASS I Guidelines → ST elevation myocardial infarction secondary prevention
  30. The Living Guidelines: STEMI PCI after Successful Fibrinolysis or for Patients not Undergoing Primary Reperfusion View the Current CLASS III Guidelines → ST elevation myocardial infarction percutaneous coronary intervention following fibrinolytic administration
  31. The Living Guidelines: STEMI PCI after Successful Fibrinolysis or for Patients not Undergoing Primary Reperfusion View the Current CLASS IIb Guidelines → ST elevation myocardial infarction percutaneous coronary intervention following fibrinolytic administration
  32. The Living Guidelines: STEMI Recommendations ACE Inhibitors Therapy View the Current CLASS I Guidelines → ST elevation myocardial infarction inhibition of the renin-angiotensin-aldosterone system at discharge
  33. The Living Guidelines: STEMI Recommendations for ACE Inhibitors Therapy View the Current CLASS IIa Guidelines → ST elevation myocardial infarction inhibition of the renin-angiotensin-aldosterone system at discharge
  34. The Living Guidelines: STEMI Recommendations for Additional Management Considerations for Beta Blocker Therapy View the Current CLASS I Guidelines → ST elevation myocardial infarction beta blocker therapy
  35. The Living Guidelines: STEMI Recommendations for Aldosterone Blockers Therapy View the Current CLASS I Guidelines → ST elevation myocardial infarction inhibition of the renin-angiotensin-aldosterone system at discharge
  36. The Living Guidelines: STEMI Recommendations for Angiotensin Receptor Blockers Therapy View the Current CLASS IIb Guidelines → ST elevation myocardial infarction inhibition of the renin-angiotensin-aldosterone system at discharge
  37. The Living Guidelines: STEMI Recommendations for Angiotensin Receptor Blockers Therapy View the Current CLASS I Guidelines → ST elevation myocardial infarction inhibition of the renin-angiotensin-aldosterone system at discharge
  38. The Living Guidelines: STEMI Recommendations for Beta Blocker Therapy View the Current CLASS III Guidelines → ST elevation myocardial infarction beta blocker therapy
  39. The Living Guidelines: STEMI Recommendations for Beta Blocker Therapy View the Current CLASS IIa Guidelines → ST elevation myocardial infarction beta blocker therapy
  40. The Living Guidelines: STEMI Recommendations for Inhibition of the Renin-Angiotensin-Aldosterone System View the Current CLASS IIa Guidelines → ST elevation myocardial infarction secondary prevention
  41. The Living Guidelines: STEMI Recommendations for Inhibition of the Renin-Angiotensin-Aldosterone System View the Current CLASS IIb Guidelines → ST elevation myocardial infarction secondary prevention
  42. The Living Guidelines: STEMI Recommendations for Inhibition of the Renin-Angiotensin-Aldosterone System View the Current CLASS I Guidelines → ST elevation myocardial infarction secondary prevention
  43. The Living Guidelines: STEMI Reperfusion View the Current CLASS I Guidelines → ST elevation myocardial infarction reperfusion therapy
  44. The Living Guidelines: STEMI Thienopyridines View the Current CLASS IIa Guidelines → ST elevation myocardial infarction thienopyridine therapy
  45. The Living Guidelines: STEMI Thienopyridines View the Current CLASS I Guidelines → ST elevation myocardial infarction thienopyridine therapy
  46. The Living Guidelines: Serial Clinical Assessment of Patients Presenting with Heart Failure. View the Current CLASS IIa Guidelines → Congestive heart failure clinical assessment
  47. The Living Guidelines: Serial Clinical Assessment of Patients Presenting with Heart Failure. View the Current CLASS IIb Guidelines → Congestive heart failure clinical assessment
  48. The Living Guidelines: Serial Clinical Assessment of Patients Presenting with Heart Failure. View the Current CLASS I Guidelines → Congestive heart failure clinical assessment
  49. The Living Guidelines: Treatment of Special Populations. View the Current CLASS IIa Guidelines → Congestive heart failure treatment of special populations
  50. The Living Guidelines: Treatment of Special Populations. View the Current CLASS I Guidelines → Congestive heart failure treatment of special populations

View ( | ) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://www.wikidoc.org/index.php/Special:ListRedirects"